Silexion Therapeutics Corp.

07/31/2026 | Press release | Distributed by Public on 07/31/2026 14:07

Management Change/Compensation (Form 8-K)

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

(b) Resignation of Director

On July 30, 2026, Professor Amnon Peled notified the Board of Directors (the "Board") of Silexion Therapeutics Corp (the "Company") of his resignation from his position as a member of the Board, for personal reasons, effective as of August 1, 2026. Professor Peled's resignation did not arise or result from any disagreement with the Company on any matter relating to the Company's operations, policies, or practices.

Silexion Therapeutics Corp. published this content on July 31, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT) on July 31, 2026 at 20:07 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]